It is in the Nature publication
Hit the full size tab Hope this helps.
Could I however suggest that one should be very careful making conclusions on this data. The Clinical response has been shown to be a very poor indication of long-term survival. Also remember that this is a open label trial and the patients gravely ill. Most Dr's would be looking for a response. This effect is one of the primary reasons that regulators don't like open label trials.
Good luck all.
It is in the Nature publication Hit the full size tab Hope this...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.020(11.8%) |
Mkt cap ! $33.89M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 15.0¢ | $101.9K | 619.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 153571 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 12550 | 1 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |